BNTC
Benitec Biopharma Inc.
Key Financials
Operating Income
$-51192000
↓ 22.6%
Net Income
$-45546000
↓ 20.1%
EPS (Diluted)
$-0.98
↑ 6.7%
Revenue
$59000
↓ 42.2%
Total Liabilities
$5.6M
↑ 144.2%
Cash & Equivalents
$180.0M
↑ 84.1%
Shareholders' Equity
$177.0M
↑ 81.9%
Total Assets
$182.6M
↑ 83.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/30/2026 | View on SEC |
| 8-K | 9/24/2026 | View on SEC |
| EFFECT | 9/21/2026 | View on SEC |
| S-3 | 9/14/2026 | View on SEC |
| 10-K | 9/14/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 8-K | 5/29/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 3 | 5/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BNTC |
| Company Name | Benitec Biopharma Inc. |
| CIK | 1808898 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | (510) 780-0819 |